Azhaar A.

Azhaar A. has a diverse work experience in the field of scientific process development. Starting in 2018, Azhaar worked as a Scientist I at Unum Therapeutics, focusing on process development. In 2020, Azhaar joined TCR² Therapeutics Inc., where they worked as a Scientist in T cell process development until 2023. Currently, Azhaar is employed at Prime Medicine, Inc. as a Scientist II, specializing in cell therapy process development.

Azhaar A. holds a Doctor of Philosophy - PhD degree in Pharmacology from the Massachusetts College of Pharmacy and Health Sciences, which was completed by the end of 2018. Prior to this, Azhaar completed a Master of Health Sciences degree in Biomedical Sciences from Quinnipiac University, which was completed by the end of 2011. The start years for both degrees were not provided.